Online Learning
Member Login
  • Home
  • About us
    • Leadership
    • Our Founding 100
  • Join us
    • Contribute to our PAC
    • Our Federal PAC
    • State Affiliate Caucus
    • State Affiliate Caucus Application
  • News
    • Resources
    • COVID-19 Resources
  • Support NDASA
  • Awards
  • Courses
  • Get involved
    • Committees
    • Board elections
  • Job Board
  • Member Login
  • NDASA University
    • My Account
    • My Courses
    • NDASA University Partner Program
  • NDASA Accreditation
  • Policies
  • Shop
  • Training opportunities
    • Webinars
      • Webinar Library
  • Security Policy
  • Refund Policy
  • Privacy Policy
  • Shipping Policy
  • Become a Trainer
  • Preferred Provider Program
  • TPA Accredidation Application
  • Mentorship
  • Meet Our Sponsors
  • Mentorship Program Pricing
  • Join our affiliate program
  • Webinar Library
  • Mentor Program Training
  • 2023 Conference Pre-Registration
NDASA logo
  • About
    • Leadership
  • Training
    • NDASA University
      • My Courses
    • Webinars
    • Accreditation
    • Mentorship
    • Webinar Library
    • 2021 Conference On Demand
  • Get involved
    • Committees
    • Become a Trainer
    • State Affiliate Caucus
    • Our Federal PAC
    • Board of Directors
  • Join us
    • Sponsorships & Advertising
    • Accreditation
    • Preferred Provider
  • News
    • Resources
    • COVID-19 Resources
  • Events
    • 2023 Conference Pre-Registration
    • 2022 Conference Highlights
    • Conference On Demand
    • IFDAT Conference
    • East Coast Job-Jam
  • Support
    • Sponsorships & Advertising
  • Contact
NDASA’s Response to Proposed Guidelines for Oral Fluid Testing and Other Changes to 49 CFR Part 40

NDASA’s Response to Proposed Guidelines for Oral Fluid Testing and Other Changes to 49 CFR Part 40

by NDASA | Apr 26, 2022 | Advocacy, DOT, Drug & Alcohol Testing, NDASA Guidance

In its role as the voice for the drug and alcohol testing industry, one of the National Drug and Alcohol Screening Association’s priorities is to provide input representing members’ interests concerning drug and alcohol testing regulations. On April 20, NDASA...
Marijuana Impairment and Drug Testing

Marijuana Impairment and Drug Testing

by Guest Contributer | Nov 9, 2021 | Drug & Alcohol Testing, Feature, Marijuana & CBD, Uncategorized

By Bill Current, founder of Current Consulting Group. Originally prepared for and published by PBSA in the Sept-Oct 2021 edition of the Journal. Read the full issue here. Which drug testing method—urine, oral fluid or hair—is best at detecting marijuana and...

Instructions for completing the Federal Drug Testing Custody and Control Form for Oral Fluid Specimen Collection

by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, Resources

When making entries on a paper CCF, use black or blue ink pen and press firmly. Collector ensures the name and address of the HHS-certified laboratory are on the top of the Federal CCF, and that the Specimen Identification (I.D.) number on the top of the Federal CCF...
Oral Fluid Testing: Soon, But Not Yet

Oral Fluid Testing: Soon, But Not Yet

by NDASA | Feb 4, 2021 | DOT, Drug & Alcohol Testing, Feature

Since the new 2020 U.S. Department of Transportation Custody and Control Form became available in September, one tiny addition has created a tremendous amount of confusion among employers, specimen collectors and others involved in DOT-mandated drug screening. The...

Search this site

Stay in touch

  • Follow
  • Follow
  • Follow
  • Follow

Give to NDASA

Invest in safe and drug-free communities and workplaces and support NDASA.
Give now

Latest News & Updates

  • Jun 08, 2022Where Are We and Where Are We Going? The State of Drug Testing and the Future
  • Jun 07, 2022NDASA Responds to SAMHSA Proposed Rules for Oral Fluid Testing in Federal Workplaces
  • Jun 07, 2022The Great Retention: How to Hold onto Your Most Valuable Asset, Your Employees
  • Jun 07, 2022First-Time Conference Attendee Vows to Return
  • Jun 02, 2022Conference 2022: Three Days Packed With Teaching, Learning, Business Building and Progress

Topics We Track

  • Advocacy (3)
  • Business Development (1)
  • Committee Reports (1)
  • DOT (5)
  • Drug & Alcohol Testing (19)
  • Drug Legislation (8)
  • Feature (50)
  • FMCSA (3)
  • For Drug Testing Industry Professionals (14)
  • For Employers and Workplace Safety & Wellness Professionals (12)
  • Industry News (10)
  • Marijuana & CBD (13)
  • Member Benefits (1)
  • Membership (3)
  • NDASA Conference (10)
  • NDASA Guidance (4)
  • Opioids (2)
  • Resources (21)
  • Substance Use (1)
  • Substance Use/Addiction (3)
  • Training (1)
  • Uncategorized (7)
  • Workplace Safety (4)

Join NDASA now. Stand for safe and drug-free workplaces and communities.

Click to join

Reach Us



1629 K St. NW, Suite 300
Washington, DC 20006



(888) 31-NDASA



info@NDASA.COM

  • Follow
  • Follow
  • Follow
  • Follow

Leave us a message

Legal Documents

  • Articles of Incorporation
  • Exemption Letter
  • IRS Designation Letter

Careers

Visit our job board

NDASA Bylaws

  • Bylaws

NDASA Policies

  • Privacy Policy
  • Security Policy
  • Refund Policy
  • Shipping Policy

Accreditation

Certification Commission for Drug and Alcohol Program Professionals ( CCDAPP)

Proud Members

U.S. Chamber of Commerce logo

U.S. Chamber of Commerce

 

Smart Approaches to Marijuana

© 2018 National Drug and Alcohol Screening Association • All Rights Reserved • Built by Media Salad